Otto Frey
Impact in
-
- Antibiotic Use and Resistance
- Pharmacology top 0.5%
- Antibiotics Pharmacokinetics and Efficacy
Papers in
- Pharmacology 31
- Antibiotics Pharmacokinetics and Efficacy 31
- Epidemiology 16
- Pneumonia and Respiratory Infections 8
- Sepsis Diagnosis and Treatment 7
- Co-authors
- Jason A. Roberts (12 shared papers)William Hope (3 shared papers)Mohd H. Abdul‐Aziz (3 shared papers)Jeffrey Lipman (2 shared papers)Timothy Felton (1 shared paper)Alexander A. Vinks (1 shared paper)Ursula Theuretzbacher (1 shared paper)Michael Neely (1 shared paper)
- Journals
- Antibiotics (9 papers)Journal of Antimicrobial Chemotherapy (4 papers)International Journal of Antimicrobial Agents (4 papers)Scientific Reports (2 papers)Infection (2 papers)
- Partner nations
- GermanyAustraliaUnited States
In The Last Decade
Otto Frey
46 papers receiving 1.5k citations
Otto Frey's Hit Papers
Peers
Comparison fields: 5 of 92
- Applied Microbiology and Biotechnology 198
- Pharmacology 991
- Molecular Medicine 281
- Clinical Biochemistry 137
- Epidemiology 426
Countries citing papers authored by Otto Frey
This map shows the geographic impact of Otto Frey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Otto Frey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Otto Frey more than expected).
Fields of papers citing papers by Otto Frey
This network shows the impact of papers produced by Otto Frey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Otto Frey. The network helps show where Otto Frey may publish in the future.
Co-authors
The 25 scholars most cited alongside Otto Frey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions Hit paper breakdown → | 2014 | 722 |
| 2 | 2019 | 65 | |
| 3 | 2018 | 60 | |
| 4 | 2018 | 60 | |
| 5 | 2016 | 55 | |
| 6 | 1999 | 36 | |
| 7 | 2016 | 36 | |
| 8 | 2019 | 35 | |
| 9 | 1995 | 34 | |
| 10 | 2017 | 32 | |
| 11 | 2015 | 30 | |
| 12 | 2015 | 27 | |
| 13 | 2023 | 23 | |
| 14 | 2018 | 22 | |
| 15 | 2017 | 20 | |
| 16 | 2022 | 19 | |
| 17 | 2016 | 18 | |
| 18 | 2022 | 18 | |
| 19 | 2021 | 18 | |
| 20 | 2016 | 17 |
About Otto Frey
Otto Frey is a scholar working on Pharmacology, Epidemiology, Infectious Diseases, Molecular Medicine and Clinical Biochemistry, having authored 48 papers that have together received 1.5k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (31 papers), Pneumonia and Respiratory Infections (8 papers), Sepsis Diagnosis and Treatment (7 papers), Antimicrobial Resistance in Staphylococcus (6 papers), Antibiotic Resistance in Bacteria (6 papers), Bacterial Identification and Susceptibility Testing (5 papers), Mechanical Circulatory Support Devices (4 papers) and Nosocomial Infections in ICU (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (198 citations), Pharmacology (991 citations), Molecular Medicine (281 citations), Clinical Biochemistry (137 citations) and Epidemiology (426 citations). Otto Frey has collaborated with scholars based in Germany, Australia and United States. Frequent co-authors include Jason A. Roberts, William Hope, Mohd H. Abdul‐Aziz, Jeffrey Lipman, Timothy Felton, Alexander A. Vinks, Ursula Theuretzbacher, Michael Neely, Joseph L. Kuti and Johan W. Mouton. Their work appears in journals such as Antibiotics, Journal of Antimicrobial Chemotherapy, International Journal of Antimicrobial Agents, Scientific Reports and Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.